| 1.92 0.07 (3.78%) | 04-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.54 | 1-year : | 4.61 |
| Resists | First : | 3.03 | Second : | 3.95 |
| Pivot price | 2.12  |
|||
| Supports | First : | 1.55 | Second : | 1.29 |
| MAs | MA(5) : | 1.86 |
MA(20) : | 2.13 |
| MA(100) : | 2.85 |
MA(250) : | 5.35 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 9.9 |
D(3) : | 6.7 |
| RSI | RSI(14): 42.9 |
|||
| 52-week | High : | 10.93 | Low : | 1.55 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ALUR ] has closed above bottom band by 26.6%. Bollinger Bands are 1.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.94 - 1.95 | 1.95 - 1.96 |
| Low: | 1.84 - 1.85 | 1.85 - 1.86 |
| Close: | 1.91 - 1.92 | 1.92 - 1.94 |
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
Thu, 04 Apr 2024
ALUR Stock Price and Chart — NYSE:ALUR — TradingView - TradingView
Thu, 04 Apr 2024
Allurion stock soars 85% on weight-loss product launch (NYSE:ALUR) - Seeking Alpha
Thu, 04 Apr 2024
Allurion Technologies, Inc. Expands Virtual Care Suite to the United States - Marketscreener.com
Thu, 04 Apr 2024
Why Allurion Technologies Stock Is Racing Higher - Allurion Technologies (NYSE:ALUR) - Benzinga
Thu, 04 Apr 2024
Allurion Expands Virtual Care Suite to the United States - Business Wire
Wed, 27 Mar 2024
Navigating the Regulatory Maze: How Compliance Challenges Threaten Allurion Technologies' Financial Health ... - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 48 (M) |
| Shares Float | 30 (M) |
| Held by Insiders | 23.8 (%) |
| Held by Institutions | 24.4 (%) |
| Shares Short | 291 (K) |
| Shares Short P.Month | 298 (K) |
| EPS | -2.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.49 |
| Profit Margin | -150.8 % |
| Operating Margin | -387.9 % |
| Return on Assets (ttm) | -80.4 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -57.1 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.11 |
| EBITDA (p.s.) | -1.64 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -64 (M) |
| Levered Free Cash Flow | -33 (M) |
| PE Ratio | -0.84 |
| PEG Ratio | 0 |
| Price to Book value | -1.3 |
| Price to Sales | 1.71 |
| Price to Cash Flow | -1.44 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|